...
首页> 外文期刊>Vaccine >Mucosal vaccination against diphtheria using starch microparticles as adjuvant for cross-reacting material (CRM197) of diphtheria toxin
【24h】

Mucosal vaccination against diphtheria using starch microparticles as adjuvant for cross-reacting material (CRM197) of diphtheria toxin

机译:使用淀粉微粒作为白喉毒素交叉反应材料(CRM197)的佐剂对白喉进行粘膜疫苗接种

获取原文
获取原文并翻译 | 示例
           

摘要

Mucosal vaccination has the advantage of eliciting a local mucosal immune response as well as a systemic response. In this investigation, polyacryl starch microparticles were conjugated to diphtheria toxin cross-reacting material (CRM197) as a mucosal adjuvant for oral or intranasal immunisation of mice. Various methods of stabilising CRM197 with formaldehyde were investigated. A good systemic and local mucosal immune response was attained with oral immunisation when CRM197 was treated with a relatively low formaldehyde concentration prior to conjugation to the microparticles. No immune response was seen after intranasal immunisation.
机译:粘膜疫苗接种具有引发局部粘膜免疫反应以及全身反应的优点。在这项研究中,聚丙烯酰胺淀粉微粒与白喉毒素交叉反应材料(CRM197)结合在一起,作为粘膜佐剂用于小鼠的口服或鼻内免疫。研究了用甲醛稳定CRM197的各种方法。当CRM197在与微粒结合之前用相对较低的甲醛浓度处理时,口服免疫获得了良好的全身和局部粘膜免疫反应。鼻内免疫后未见免疫反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号